Frontier Capital Management CO LLC Pacira Bio Sciences, Inc. Transaction History
Frontier Capital Management CO LLC
- $10.2 Billion
- Q1 2024
A detailed history of Frontier Capital Management CO LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 1,914,343 shares of PCRX stock, worth $54.8 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
1,914,343
Previous 2,084,542
8.16%
Holding current value
$54.8 Million
Previous $70.3 Million
20.47%
% of portfolio
0.55%
Previous 0.74%
Shares
21 transactions
Others Institutions Holding PCRX
# of Institutions
286Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$226 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$146 Million0.0% of portfolio
-
State Street Corp Boston, MA1.9MShares$54.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$53.8 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$46.6 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.31B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...